Biotech

All Articles

' Scientific instinct' led FDA experts to support Zevra's rare disease med

.Zevra Rehabs' unusual health condition medication seems to become on the course to permission this ...

Pfizer takes $230M attacked after axing stopped working DMD genetics therapy

.Pfizer's stage 3 Duchenne muscle dystrophy (DMD) gene treatment breakdown has gone a $230 million g...

AC Immune views 'site' possible in Alzheimer's drug data

.After greater than twenty years of focus on neurodegenerative illness, Swiss biotech AC Immune clai...

GSK loses ph. 2 HPV injection over lack of best-in-class prospective

.GSK has actually scrapped a phase 2 human papillomavirus (HPV) vaccination coming from its own pipe...

OS Therapies refiles $6M IPO to fund HER2 drug, preclinical ADCs

.OS Therapies will note on the NYSE American inventory exchange this morning through a $6.4 million ...

ALX's fizzling CD47 reaction price sends out stock spiraling down

.ALX Oncology's phase 2 stomach cancer reaction rate has weakened. After observing its own CD47 bloc...

Ionis centers eye illness from aim ats of Roche-partnered possibility after records dissatisfy

.One More of Ionis Pharmaceuticals' vital midphase readouts has actually fallen short of requirement...

Biogen's CEO claimed no risky deals in 2023. He prepares to become strong

.While Biogen's pharma peers are actually searching for late-stage assets along with little bit of t...

Instil refills pipeline in $2B biobucks deal with ImmunOnco

.Instil Biography has actually been a biotech seeking a pipe after it scrapped its lead assets over ...

Biogen walks away from Denali Alzheimer's collab

.Biogen has handed back liberties to a very early Alzheimer's condition program to Denali Rehabs, go...